Kadcyla (ado-trastuzumab emtansine) - Roche
Jivadco (trastuzumab duocarmazine) - Byondis, Medac
Trodelvy (sacituzumab govitecan-hziy) - Gilead
datopotamab deruxtecan (DS-1062a) - Daiichi Sankyo, AstraZeneca
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
Nerlynx (neratinib) - Puma
capecitabine - Generic mfg.
lapatinib - Generic mfg.
https://congresso.aiom.it/C_Common/Download.asp?file=/$Site$/files/doc/2024_TMJ_110_2S_XXVI_AIOM_abstract-book.pdf
 
Della Rossa S.1; Cucciniello L.1; Giudici F.2; Di Nardo P.3; Dri A.1; Zottarelli E.1; Noto C.4; Foffano L.1; Pastò B.1; Vida R.1; Bolzonello S.5; Da Ros L.5; Cudia G.6; Nascimbeni E.6; Lisanti C.7; Spazzapan S.5; Serraino D.2; Gerratana L.1; Puglisi F.1
 
Nov 17, 2024
 
Prev Next